Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.

导出 LinkOut

翻译打印收藏纠错

作者： Elena,Boggio ^[1] ; Casimiro Luca,Gigliotti ^[1] ; Riccardo,Moia ^[2] ; Annamaria,Scotta ^[3] ; Ilaria,Crespi ^[3] ; Paola,Boggione ^[3] ; Lorenzo,De Paoli ^[2] ; Clara,Deambrogi ^[3] ; Massimiliano,Garzaro ^[2] ; Matteo,Vidali ^[3] ; Annalisa,Chiocchetti ^[2] ; Ian,Stoppa ^[3] ; Roberta,Rolla ^[1] ; Chiara,Dianzani ^[3] ; Chiara,Monge ^[1] ; Nausicaa,Clemente ^[1] ; Gianluca,Gaidano ^[1] ; Umberto,Dianzani ^[3]

作者单位： Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Università del Piemonte Orientale, Novara, Italy. ^[1] Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. ^[2] Maggiore della Carità University Hospital, Novara, Italy. ^[3] Department of Scienza e Tecnologia del Farmaco, University of Turin, Turin, Italy. ^[4]

关键词 inducible T-cell co-stimulator (ICOS)/ICOS ligand (ICOSL) system multiple myeloma sICOS and sICOSL

主题词人类(Humans);配体(Ligands);多发性骨髓瘤(Multiple Myeloma);T淋巴细胞(T-Lymphocytes);肿瘤微环境(Tumor Microenvironment)

DOI 10.1111/bjh.17968

PMID 34954822

发布时间 2022-04-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交